We examined clinical outcomes of co-infection with influenza viruses, respiratory syncytial
virus, or adenoviruses in 212 466 adults with SARS-CoV-2 infection who were admitted to …

Background Immunocompromised patients may be at higher risk of mortality if hospitalised
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients. …

The increasing body of literature describing the role of host factors in COVID-19 pathogenesis
demonstrates the need to combine diverse, multi-omic data to evaluate and substantiate …

COVID-19 is clinically characterised by fever, cough, and dyspnoea. Symptoms affecting
other organ systems have been reported. However, it is the clinical associations of different …

Background Severe COVID-19 is characterised by fever, cough, and dyspnoea. Symptoms
affecting other organ systems have been reported. However, it is the clinical associations of …

… Author links open overlay panel Maaike C. Swets MD 1 2 , Fabian Termorshuizen PhD 3
4 , Nicolette F. de Keizer PhD 3 4 , Judith van Paassen MD 5 , Meindert Palmen MD, PhD 6 , …

Objectives Interleukin (IL)-6 inhibitors are administered to treat patients hospitalized with
COVID-19. In 2021, due to shortages, different dosing regimens of tocilizumab, and a switch to …

Background: An outbreak of severe acute hepatitis of unknown aetiology (AS-Hep-UA) in
children during 2022 has subsequently been linked to infections by adenovirus-associated …

Optimising statistical power in early-stage trials and observational studies accelerates
discovery and improves the reliability of results. Ideally, intermediate outcomes should be …

An increasing body of literature describes the role of host factors in COVID-19 pathogenesis.
There is a need to combine diverse, multi-omic data in order to evaluate and substantiate …